These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 868906)

  • 21. Amikacin therapy of gram-negative bacteremia.
    Tally FP; Gorbach SL
    Am J Med; 1977 Jun; 62(6):936-9. PubMed ID: 868909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 'high-dose' amikacin in children.
    Kumor KM; McDonald JM; Lietman PS
    Dev Pharmacol Ther; 1984; 7(6):368-76. PubMed ID: 6518944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amikacin therapy for serious gram-negative infection.
    Pollock AA; Berger SA; Richmond AS; Simberkoff MS; Rahal JJ
    JAMA; 1977 Feb; 237(6):562-4. PubMed ID: 576282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycoside toxicity in infants and children.
    McCracken GH
    Am J Med; 1986 Jun; 80(6B):172-8. PubMed ID: 3524215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amikacin therapy for gram-negative septicemia.
    Meyer RD; Lewis RP; Finegold SM
    Am J Med; 1977 Jun; 62(6):930-5. PubMed ID: 868908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of single daily dose gentamicin in stem cell transplantation.
    Warkentin D; Ippoliti C; Bruton J; Van Besien K; Champlin R
    Bone Marrow Transplant; 1999 Jul; 24(1):57-61. PubMed ID: 10435736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
    Guh JY; Su YH; Chen HJ; Tsai JH
    Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
    Moore RD; Smith CR; Lietman PS
    J Infect Dis; 1984 Jan; 149(1):23-30. PubMed ID: 6693788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ototoxicity and nephrotoxicity of netilmicin.
    Federspil P
    Infection; 1976; 4(4):211. PubMed ID: 1017880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States.
    Lane AZ; Wright GE; Blair DC
    Am J Med; 1977 Jun; 62(6):911-8. PubMed ID: 868905
    [No Abstract]   [Full Text] [Related]  

  • 32. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amikacin in the treatment of gram-negative pneumonia.
    Trenholme GM; McKellar PP; Rivera N; Levin S
    Am J Med; 1977 Jun; 62(6):949-53. PubMed ID: 868912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily gentamicin in infants and children: a prospective cohort study evaluating safety and the role of therapeutic drug monitoring in minimizing toxicity.
    Best EJ; Gazarian M; Cohn R; Wilkinson M; Palasanthiran P
    Pediatr Infect Dis J; 2011 Oct; 30(10):827-32. PubMed ID: 21577177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of ototoxicity associated with intravenous drip infusion of amikacin].
    Maeyama T; Hashimoto M; Ogawa K; Hanamure Y; Kiyota R; Kurono Y; Iida F; Ohhori Y; Ogawa K
    Jpn J Antibiot; 1983 Oct; 36(10):2813-9. PubMed ID: 6674516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
    Gatell JM; San Miguel JG; Zamora L; Araujo V; Bonet M; Bohé M; Jimenez de Anta MT; Farré M; Elena M; Ballesta A; Marin JL
    Antimicrob Agents Chemother; 1983 Jun; 23(6):897-901. PubMed ID: 6614894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of amikacin and gentamicin in the treatment of urinary tract infections.
    Gilbert DN; Eubanks N; Jackson J
    Am J Med; 1977 Jun; 62(6):924-9. PubMed ID: 868907
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.
    Kos M; Jazwinska-Tarnawska E; Hurkacz M; Orzechowska-Juzwenko K; Pilecki W; Klempous J
    Int J Clin Pharmacol Ther; 2003 Jul; 41(7):281-6. PubMed ID: 12875343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing for ototoxicity: amikacin and gentamicin.
    Carey JT; Wichter MD
    N Engl J Med; 1977 May; 296(19):1124. PubMed ID: 850531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.